Nan Zheng

6PUBLICATIONS
4CO-AUTHORS
Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPharmacogenomicsIndustrial molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 05, 2026
Discovery and Preclinical Evaluation of TPM003: A Novel GLP-1/GIP/Glucagon Triple Hormone Receptor Agonist with Robust Efficacy in Obesity and NASH.

Nan Zheng, Longfang Tu, Pu Xu

|Dec 22, 2025
Development of a Long-Acting and Stapled Dual Amylin and Calcitonin Receptor Agonist as Monotherapy and Combination with GLP-1R Agonists for the Treatment of Obesity.

Yaqi Zhou, Pu Xu, Jiang Lu

|Nov 12, 2025
Engineering of an Ultralong-Acting and Nonaggregating Dual Amylin and Calcitonin Receptor Agonist with Durable Efficacy in Obesity and Diabetes.

Nan Zheng, Rongfang Chen, Luying Yang

|Jul 24, 2025
Long-Acting and Stapled GLP-1R/GIPR/GCGR Triple Agonist for the Treatment of Obesity and Atherosclerosis.

Yaqi Zhou, Longfang Tu, Xueying Wang

|Oct 31, 2023
Serine-mediated hydrazone ligation displaying insulin-like peptides on M13 phage pIII.

Yi Wolf Zhang, Nan Zheng, Danny Hung-Chieh Chou

|Jun 23, 2021
Discovery of Methylene Thioacetal-Incorporated α-RgIA Analogues as Potent and Stable Antagonists of the Human α9α10 Nicotinic Acetylcholine Receptor for the Treatment of Neuropathic Pain.

Nan Zheng, Sean B Christensen, Cheryl Dowell

Pageof 1

Frequent Collaborators

2 joint publications

Danny Hung-Chieh Chou

1 joint publications

Yi Wolf Zhang

1 joint publications

Xiaochun Xiong

1 joint publications

Xiao-Xuan Su